BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 198304)

  • 1. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
    Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
    Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
    [No Abstract]   [Full Text] [Related]  

  • 2. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
    Bauer K
    Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
    Garland AJ; Mowat GN; Fletton B
    Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Several criteria of evaluation of foot-and-mouth disease virus reproduced in cell cultures in suspension].
    Girard HC
    Dev Biol Stand; 1976; 35():91-6. PubMed ID: 71255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of type A foot-and-mouth disease virus subtypes by double- and radial-immunodiffusion analysis.
    Lobo CA; Cowan KM; Trautman R; Hanson RP
    Am J Vet Res; 1974 Aug; 35(8):1121-6. PubMed ID: 4368590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities of biophysicochemical antigen control in vaccine production using foot-and-mouth disease virus as an example (review)].
    Liebermann H; Kwasniowski W; Strebelow G
    Arch Exp Veterinarmed; 1988 Mar; 42(2):165-73. PubMed ID: 2840042
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle.
    Pay TW; Hingley PJ
    Dev Biol Stand; 1986; 64():153-61. PubMed ID: 3025036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
    Rweyemamu MM; Pay TW; Parker MJ
    Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparatve serological and immunological study of strains of foot-and-mouth disease virus type "O" isolated in Europe between 1963 and 1966].
    Moosbrugger GA; Leunen J; Mackowiak C; Fontaine J; Roumiantzeff M
    Bull Off Int Epizoot; 1967; 67(5):711-29. PubMed ID: 4303616
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of suspension cultures for FMD vaccine production. Criteria for the evaluation of cells, virus and vaccine.
    Nardelli L; Panina GF
    Dev Biol Stand; 1976; 35():9-25. PubMed ID: 198318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Viral particle specific serums, used in complement fixation tests of foot-and-mouth disease virus].
    Roumiantzeff M; Fayet MT
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):833-51. PubMed ID: 4312138
    [No Abstract]   [Full Text] [Related]  

  • 12. Three variants of foot-and-mouth disease virus type O: cell culture characteristics and antigenic differences.
    McVicar JW; Sutmoller P
    Am J Vet Res; 1972 Aug; 33(8):1627-33. PubMed ID: 4340052
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of antigen content and effectiveness of foor-and-mouth disease vaccines.
    Czelleng F; Sólyom F
    Dev Biol Stand; 1976; 35():295-6. PubMed ID: 198298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some problems of testing foot-and-mouth disease vaccines. II. Potency testing.
    Soós T
    Acta Vet Hung; 1987; 35(3):331-42. PubMed ID: 2829602
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivated-concentrated virus antigen for indirect complement fixation test of foot-and-mouth disease.
    Sakaki K; Suphavilai P; Chandarkeo T
    Natl Inst Anim Health Q (Tokyo); 1978; 18(3-4):128-34. PubMed ID: 216926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the correct quantitative relations of antigen components in mono-, bi- and trivalent foot-and-mouth disease vaccine preparations.
    Sólyom F; Czelleng F
    Dev Biol Stand; 1976; 35():289-94. PubMed ID: 198297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testing the activity of anti-foot-and-mouth disease vaccine in cattle: quantitative methods of antigenic extinction].
    Terré J; Stellmann C; Brun A; Favre H; Fontaine J
    Dev Biol Stand; 1976; 35():357-67. PubMed ID: 198306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast modification of foot-and-mouth disease virus by selecting clones in bovines.
    Bernal C; Balestrini J; Gomez G; Castañeda J
    Dev Biol Stand; 1976; 35():471-9. PubMed ID: 198313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antigenic properties of some strains of foot-and-mouth disease virus].
    Bazadze TsV
    Veterinariia; 1971 Aug; 9():34-5. PubMed ID: 4334672
    [No Abstract]   [Full Text] [Related]  

  • 20. [The efficacy of foot and mouth disease vaccines after long- term storage].
    Wittmann G
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.